Home > For Consumers > Aboriginal and Torres Strait Islander Health > Publications and Reporting > OATSIH Publications

OATSIH Publications

Listings on the PBS for Aboriginal and Torres Strait Islander People

This list details all PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people. This is based on the 1 November 2012 Pharmaceutical Benefits Schedule.

PDF version: PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people (PDF 416 KB)

---

HTML / Text version of the PBS items

Authority Required—Streamlined authority number 2354.
For the treatment of a fungal or yeast infection in an Aboriginal or Torres Strait Islander person.

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
9024Y	Ketoconazole Cream 20mg per g (2%), 30g	Nizoral 2% Cream	Johnson & Johnson	1	2
9025B	Ketoconazole Shampoo 10mg per g (1%), 100mL	Nizoral 1%	Johnson & Johnson	1	1
1574W	Ketoconazole Shampoo 20mg per g (2%), 60mL	Nizoral 2%	Johnson & Johnson	1	1
9026C	Miconazole nitrate Cream 20mg per g (2%), 15g	Daktarin	Johnson & Johnson	2	3
9027D	Miconazole nitrate Cream 20mg per g (2%), 30g	Daktarin	Johnson & Johnson	1	2
9028E	Miconazole nitrate Cream 20mg per g (2%), 70g	Daktarin	Johnson & Johnson	1	1
9029F	Miconazole nitrate Powder 20mg per g (2%), 30g	Daktarin	Johnson & Johnson	1	2
9030G	Miconazole nitrate Lotion 20mg per mL (2%), 30g	Daktarin	Johnson & Johnson	1	2
9031H	Miconazole Tincture 20mg per mL (2%), 30mL	Daktarin	Johnson & Johnson	1	2
1698J	Nystatin Cream 100,000 units per g, 15g	Mycostatin	Fawns and McAllan	2	3
9160D	Terbinafine hydrochloride Cream 10mg per g (1%), 15g	Lamisil	Novartis	2	3

Authority Required—Streamlined authority number 2384.
For prophylaxis of thiamine deficiency in an Aboriginal or Torres Strait islander Person.Top of page

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
1070H	Thiamine hydrochloride tablet 100mg	Betamin	Sanofi-Aventis	100	2

Authority Required

• streamlined authority number 2446 for treatment of whipworm infestation in an Aboriginal and Torres Strait Islander person; or
• streamlined authority number1388 for Strongyloidiasis; or
• streamlined authority number 3242 for Treatment of hookworm infestation.

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
9047E	AlbendazoleTablet 200mg	Zentel	GlaxoSmithKline	6	0

Authority Required—For treatment of chronic suppurative otitis media in an Aboriginal or Torres Strait Islander person aged 1 month or older; or treatment of suppurative otitis media in a patient less than 18 years of age with perforation of the tympanic membrane; or treatment of chronic suppurative otitis media in a patient less than 18 years of age with a grommet in situ.

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
2480M	Ciprofloxacin Ear drops 3 mg per mL (0.3%), 5 mL	Ciloxan	Alcon Laboratories	1	1

Authority Required—For Treatment of a dermatophyte infection in an Aboriginal or Torres Strait Islander person where topical treatment has failed.Top of page

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
2285G	Terbinafine Tablet 250mg (as hydrochloride)	Lamisil GenRx Terbinafine Tamsil Terbihexal Terbinafine 250 Sebifin 250 Terbix-250 Terbinafine-GA Terbinafine-DRLA Tinasil	Novartis GenRx Sigma Pharmaceuticals Sandoz Pharmacor Ranbaxy Meditech Ascent Pharma Dr Reddy’s Laboratories Alphapharm	42 42 42 42 42 42 42 42 42 42	0 0 0 0 0 0 0 0 0 0

Authority Required—For nicotine dependence in an Aboriginal or Torres Strait Islander person as the sole PBS-subsidised therapy.

Note: Only two courses of PBS-subsidised nicotine replacement therapy will be authorised per year. No applications for increased maximum quantities and/or repeats will be authorised. Benefit is improved if used in conjunction with a comprehensive support and counselling program.

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
9198D	Nicotine Transdermal patch releasing approx.. 15mg per 16 hours	Nicorette Patch	Johnson and Johnson	28	2 per yr
5465P	Transdermal patch releasing approx.. 21mg per 24 hours	Nicobate P	GlaxoSmithKline	28	2 per yr
5571F	Transdermal patch releasing approx.. 21mg per 24 hours	Nicotinell Step 1	Novartis	28	2 per yr

Authority Required—Streamlined authority number 3136 for nasal colonisation with Staphylococcus aureus in an Aboriginal and Torres Strait Islander person.Top of page

Note: No applications for increased maximum quantities and/or repeats will be authorised.

Item code	Name Manner of administration	Brand Name	Manufacturer	Max Quantity	No. of Repeats
9440W	Nasal Ointment Mupirocin Nasal ointment 20mg (as Calcium) per g (2%), 3g	Bactroban	GlaxoSmithKline	1	0

All information in this publication is correct as of November 2012
The Pharmaceutical Benefits Schedule provided more information regarding medicines subsidised by the Australian Government as well as information for consumers, carers, health professionals and the pharmaceutical industry. The PBS is part of Australia's broader National Medicines Policy (NMP).

If you are unable to download the PDF please email OATSIH 19.2 enquiries mailbox or phone: 02 6289 4465.Top of page